RESEARCHER PROFILE
M Hrubisko
← Back to Slovak Medical University
M
Slovak Medical University
M Hrubisko works in Hematopoietic Stem Cell Transplantation, Blood transfusion and management, Hematological disorders and diagnostics, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research. Recorded institutional associations include Slovak Medical University.
85Publications
778Citations
9H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
2020 · 367 citationsEffects of Long-Term Intravenous Ibandronate Therapy on Skeletal-Related Events, Survival, and Bone Resorption Markers in Patients With Advanced Multiple Myeloma
2002 · 159 citationsHistorical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide
2011 · 69 citationsRituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial
2016 · 46 citationsThe role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents
1993 · 37 citationsRecommendations for the diagnosis and treatment of patients with polycythaemia vera
2018 · 13 citationsChimerism 46,XX/46,XY in a phenotypic female
1980 · 12 citationsIsolated extra-medullary relapse of acute leukemia following allogeneic bone marrow transplantation.
2008 · 11 citationsRituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial
2019 · 9 citationsSuitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump
1992 · 7 citationsDrug resistance induction and cross-resistance studies with Pt-complexes.
1984 · 6 citationsAutologous hematopoietic stem cell transplantation for acute myeloid leukemia – single center experience
2017 · 6 citationsDrug-resistance associated alterations of cell surface antigen expression in a human anthracycline-resistant ovarian carcinoma cell line.
1994 · 5 citationsIs there still a role for autologous stem cell transplantation in acute myeloid leukemia?
2012 · 5 citationsIn vivo and in vitro effectivity of some platinum complexes.
1984 · 4 citationsAllogeneic peripheral blood stem cell transplantations in children--a single center experience.
2004 · 3 citationsCardiovascular complications among hematopoietic cell transplantation survivors – the role of cardiomarkers
2022 · 3 citations[Osteoporosis in multiple myeloma].
1998 · 2 citations[Autologous stem cell transplantation in a patient with juvenile chronic arthritis].
1999 · 2 citationsClinical utilization of plasmapheresis and cyclophosphamide in the treatment of malignant lymphoproliferative processes.
1973 · 2 citationsComparison of the effectivity of two diaminocyclohexane Pt-complexes.
1985 · 2 citationsGrowth, flow cytometric, and karyological characterization of L1210 cell sublines resistant to various Pt derivatives.
1989 · 2 citationsClinical experience and safety of venetoclax in the treatment of patients with chronic lymphocytic leukemia – real-world data from a hemato-oncology center
2025 · 2 citationsAntitumor activity of four polymer bound trans-1,2-diaminocyclohexaneplatinum(II)-4-carboxyphtalate complexes tested in different model systems.
1986 · 1 citations[Cisplatin and its derivatives--effective antineoplastic agents].
1987 · 1 citations
